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Metabolic demand and renal mass supply affecting the early
graft function after living donor kidney transplantation.
Background. Graft mass has been demonstrated to be a de-
terminant of outcome after kidney transplantation. An insuffi-
cient nephron might fail to meet the metabolic demands of the
recipient and lead to hyperfiltration.
Methods. The study population was restricted to live donor
transplants demonstrating immediate function that had neither
ischemic injury, episodes of rejection, nor any complications
that resulted in a functional decrease of the graft. The donated
kidney was weighed just after cold flush, and the recipient’s
serum creatinine (Scr) was measured on a daily basis postop-
eratively. When the recipient’s Scr reached the baseline, the
recipient’s 24-hour urine was collected for the amount of pro-
teinuria (Upr), creatinine excretion (Ucr), and creatinine clear-
ance (Ccr) calculation. As the parameters of the metabolic
demands of donor and recipient, body weight, height, body
surface area, lean body weight, and body mass index were
noted. Pearson correlation and linear regression were carried
out.
Results. The graft function, as measured by Scr, Ucr, and
Upr, was not directly correlated with the graft weight but rather
correlated with the ratios of graft weight to the parameters of
recipient’s metabolic demands. As recipient size increased, the
metabolic demand has increased. The parameters of recipient’s
metabolic demands were directly correlated with Scr and Ucr,
rather than with Upr.
Conclusion. During living donor and recipient matching,
both the potential sizes of the donated kidney and the recip-
ient should be considered in terms of the early graft function
after transplantation.
Graft function after kidney transplantation is influ-
enced by many factors that interact in a complex way.
These factors can be classified as donor-dependent and
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recipient-dependent. They also include the operative pro-
cedures of procurement and implantation, the process of
kidney preservation, ischemia and reperfusion injury, and
pre- or post-transplant course, including episodes of re-
jection, immunosuppression, diabetes, and other compli-
cations.
Renal graft mass has been demonstrated to be a deter-
minant of outcome after kidney transplantation [1]. An
insufficient nephron mass might fail to meet the metabolic
demands of the kidney recipient and lead to hyperfiltra-
tion. Since the hyperfiltration hypothesis was suggested
to be an important factor in the progression of kidney
disease [2], additional evidence has accumulated, impli-
cating it as a risk factor for the development of chronic
allograft failure [3, 4]. The incidence of hyperfiltration
may partly be determined by the initial nephron mass
provided by a transplanted kidney, as well as further
loss of nephrons as a result of episodes of rejection and
the use of nephrotoxic immunosuppression. In order to
prevent hyperfiltration, it is important to initially pro-
vide an adequate functioning nephron number to meet
the metabolic demands of a recipient, as well as allow
adequate nephron mass in case of episodes of rejec-
tion, nephrotoxic drugs, or other potential injury. While
nephron number of a kidney cannot be measured in vivo,
its weight appears to be the best surrogate marker [5,
6]. An inadequate renal mass to meet metabolic demand
might trigger hyperfiltration-mediated damage and, con-
sequently, contribute to the appearance and progression
of renal allograft nephropathy [7]. In the clinical setting,
parameters such as body weight [8], height, body surface
area (BSA) [9], lean body weight (LBW), and body mass
index (BMI) [10, 11] might represent the metabolic de-
mands of the potential kidney recipient.
Support for the hyperfiltration theory of chronic al-
lograft nephropathy, however, is based on the several
hypotheses on each side of ‘demand’ or ‘supply.’ Donor
and recipient size, as well as renal allograft mass, may all
potentially affect long-term outcome after kidney trans-
plantation. A better understanding of the impact of these
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clinical parameters on early graft function may lead to
better outcomes after kidney transplantation.
METHODS
A prospective analysis of the effect of renal allograft
mass on outcome after living donor kidney transplanta-
tion was performed at Ajou University and Yonsei Uni-
versity between 1999 and 2003. In order to limit other
factors that might affect renal allograft function, the
study population was restricted to live donor transplants
demonstrating immediate graft function. We attempted
to specifically analyze the impact of the metabolic de-
mands and renal supply on graft outcome. To eliminate
the possible impact of immunologic or nonimmunologic
factors on graft function, we excluded recipients with pre-
or post-transplant diabetes, kidney transplants from ca-
daveric donors, post-transplant ischemic injuries of the
graft, episodes of rejection, drug toxicities, systemic or
local infections, or any complications, such as vascular or
urologic adverse events postoperatively, which resulted
in functional decrease of the kidney graft. Immunosup-
pression consisted of cyclosporine (N = 149, 76.4%)
or tacrolimus (N = 46, 23.6%), corticosteroids and, in
some cases, azathioprine or mycophenolate mofetil. Cy-
closporine or tacrolimus was given orally at a dose of
10 mg/kg/day or 0.2 mg/kg/day, respectively, starting at
two days before transplantation. Within a month after
transplantation, the dose of the drug was individually ad-
justed with goal trough blood level between 200 ng/mL
and 250 ng/mL for cyclosporine or between 10 ng/mL and
15 ng/mL for tacrolimus.
The donated kidney was weighed just after cold flush
during the operative procedures. The recipient’s serum
creatinine (Scr) was measured on a daily basis postoper-
atively. When the Scr of the recipient reached the baseline
level within a month post-transplantation, the recipient’s
24-hour urine was collected for the amount of proteinuria
(Upr), creatinine excretion (Ucr), and creatinine clear-
ance (Ccr) calculation. The recipients were also weighed
on a daily basis, post-transplantation. Dry weight of recip-
ients was used as a parameter of metabolic demands. Dry
weight was defined as the recipient’s body weight within
a month post-transplantation, when the serum creatinine
reached baseline, the body weight of recipient maintained
stable at the nadir, and the recipient was not on diuretics.
Heights of both donors and recipients were recorded. The
BSA of both were calculated with the DuBois formula
[12], the LBW with the formula, 1.10 × weight (kg) − 128
× (weight2/(100 × height (m)2) in men, or 1.07 × weight
(kg) − 148 × (weight2/(100 × height (m)2) in women,
and the BMI with the formula weight (kg)/height (m)2.
Other donor and recipient characteristics were recorded,
including age, gender, duration of dialysis, degree of HLA
match, and type and dose of immunosuppression.
For bivariate analysis, the correlations between each
pairs of continuous variables were analyzed using
Pearson’s correlation testing, and P ≤ 0.050 was consid-
ered significant. Significantly correlated pairs of variables
with a P ≤ 0.050 in the bivariate analysis were entered
into the linear regression analysis to estimate the B coeffi-
cients (unstandardized), beta-coefficients (standardized)
with P values of the independent variables, including the
parameters of the metabolic demands such as age, body
weight, height, BSA, LBW, and BMI of both donors and
recipients, as well as the ratios of graft weight to the pa-
rameters of recipient and the ratios of the parameters
of donor to those of recipient. Dependent variables for
the linear regression were the graft weight and the post-
transplant Upr, Scr, Ucr, and Ccr of the recipients. Sta-
tistical analysis was performed using SPSS release 10.0
(SPSS, Inc., Chicago, IL, USA). Continuous variables are
expressed as the mean ± standard deviation (SD).
RESULTS
During the study period, 195 kidney transplants were
performed that met the study criteria. The average age,
weight, and height of donors were 38.7 years ± 10.3, 63.0
kg ± 10.4, and 165.2 cm ± 8.2, respectively. Their calcu-
lated BSA, LBW, and BMI were 1.7 m2 ± 0.2, 48.3 kg ±
8.0, and 23.0 kg/m2 ± 2.8, respectively. Donated kidneys
weighed 215.5 g ± 40.5 (range 108.9 g to 335.0 g).
The average age, weight, and height of recipients were
37.2 years ± 10.2, 57.0 kg ± 9.8, and 166.8 cm ± 8.8, re-
spectively. Their calculated BSA, LBW, and BMI were 1.6
m2 ± 0.2, 46.4 kg ± 7.7, and 20.4 kg/m2 ± 2.7, respectively.
As demonstrated in Table 1, variables significantly cor-
related with the graft weight by Pearson’s bivariate anal-
ysis were donor age (P = 0.002), body weight (P < 0.001),
height (P = 0.031), BSA (P < 0.001), LBW (P = 0.001),
and BMI (P < 0.001). In addition, the recipient’s post-
transplant Upr was also inversely correlated (P < 0.001).
Factors identified to independently predict graft weight
by linear regression multivariate analysis are listed in
Table 1 and included donor age [P = 0.013, beta-
coefficient = 0.172, 95% confidence interval (CI) 0.14
to 1.19] and recipient post-transplant Upr (P < 0.001,
beta-coefficient = −0.399, 95% CI −0.11 to −0.05).
Donor and recipient variables were also examined for
the extent of correlation (Pearson’s bivariate analysis)
and ability to independently predict (linear regression
multivariate analysis) measures of early graft function
such as Upr, Scr, Ucr, and Upr. The variables signifi-
cantly inversely correlated with the Upr (Table 2) were
graft weight (P < 0.001), the ratio of graft weight to re-
cipient body weight (P < 0.001), the ratio of graft weight
to recipient BSA (P < 0.001), the ratio of graft weight to
recipient LBW (P = 0.001), the ratio of graft weight to
recipient BMI (P < 0.001), and the ratio of donor BMI
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Table 1. Donor characteristics correlating with or independently predicting donor renal graft weight
Correlationsa Coefficientsb
Independent variables Pearson’s P value B b t P value
Donor age .213 0.002 .67 .17 2.51 0.013
Donor body weight .313 <0.001 −1.31 −.34 −.22 0.823
Donor height .135 0.031 −2.50 −.51 −.37 0.712
Donor BSA .273 <0.001 412.36 1.71 .65 0.515
Donor LBW .233 0.001 −2.82 −.56 −1.70 0.090
Donor BMI .317 <0.001 −1.78 −1.12 −.16 0.877
Recipient Upr −.312 <0.001 −.07 −.40 −4.98 <0.001
(constant) 168.26 −.28 0.782
R = .506, F = 9.06, P < 0.001.
aDetermined by Pearson’s bivariate analysis.
bDetermined by linear regression multivariate analysis.
Table 2. Donor, recipient, and graft characteristics correlating with or independently predicting recipient post-transplant urinary excretion
of protein
Correlationsa Coefficientsb
Independent variables Pearson’s P value B b t P value
Graft weight −.289 <0.001 −19.78 −4.85 −4.97 <0.001
Graft weight/recipient weight −.239 <0.001 −530.15 −3.52 −2.90 0.004
Graft weight/recipient BSA −.263 <0.001 26.58 4.72 2.80 0.006
Graft weight/recipient LBW −.220 0.001 −88.57 −0.69 −1.30 0.196
Graft weight/recipient BMI −.299 <0.001 276.62 4.28 5.50 <0.001
Donor BMI/recipient BMI −.138 0.029 59.76 0.07 .70 0.484
Recipient BMI .211 0.002 120.87 2.02 6.84 <0.001
(constant) −2268.65 −5.96 <.001
R = .534, F = 10.31, P < 0.001.
aDetermined by Pearson’s bivariate analysis.
bDetermined by linear regression multivariate analysis.
Table 3. Donor, recipient, and graft characteristics correlating with or independently predicting recipient post-transplant serum creatinine
Correlationsa Coefficientsb
Independent variables Pearson’s P value B b t P value
Graft weight/recipient weight −.342 <0.001 2.90 9.18 2.67 0.008
Graft weight/recipient BSA −.291 <0.001 −1.36 −11.50 −2.28 0.024
Graft weight/recipient LBW −.404 <0.001 .39 1.45 .87 0.387
Graft weight/recipient BMI −.120 0.049 −.54 −4.01 −2.87 0.005
Donor weight/recipient weight −.447 <0.001 −1.39 −1.01 −.87 0.384
Donor BSA/recipient BSA −.513 <0.001 −.54 −0.21 −.27 0.790
Donor LBW/recipient LBW −.512 <0.001 .98 0.68 1.74 0.083
Donor BMI/recipient BMI −.158 0.015 .84 0.44 1.11 0.267
Recipient height .580 <0.001 .02 0.42 .27 0.784
Recipient weight .456 <0.001 −.25 −7.23 −2.14 0.034
Recipient BSA .544 <0.001 6.54 3.20 1.01 0313
Recipient LBW .565 <0.001 .08 1.86 1.54 0215
Recipient BMI .159 0.014 .30 2.40 1.91 0058
Recipient Ucr .580 <0.001 .03 0.30 3.46 0001
(constant) −8.08 −1.29 .200
R = .692, F = 10.67, P <.001.
aDetermined by Pearson’s bivariate analysis.
bDetermined by linear regression multivariate analysis.
to recipient BMI (P = 0.029). Recipient BMI was also sig-
nificantly correlated with Upr (P = 0.002). Factors inde-
pendently predictive of the Upr (Table 2) included graft
weight (P < 0.001, beta-coefficient = −4.850, 95% CI
−27.63 to −11.94), the ratio of graft weight to recipient
body weight (P = 0.004, beta-coefficient = −3.518, 95%
CI −891.38 to −168.92), the ratio of graft weight to re-
cipient BSA (P = 0.006, beta-coefficient = 4.725, 95% CI
7.82 to 45.35), the ratio of graft weight to recipient BMI
(P < 0.001, beta-coefficient = 4.283, 95% CI 177.40 to
375.85), and recipient BMI (P < 0.001, beta-coefficient =
2.016, 95% CI 85.99 to 155.75).
The variables significantly correlated with the Scr
(Table 3) were the ratio of graft weight to recipient body
weight (P < 0.001, inverse correlation), the ratio of graft
weight to recipient BSA (P < 0.001, inverse correlation),
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Table 4. Donor, recipient and graft characteristics correlating with or independently predicting recipient post-transplant urinary excretion of
creatinine
Correlationsa Coefficientsb
Independent variables Pearson’s P value B b t P value
Graft weight/recipient weight −.477 <0.001 464.01 1.53 .51 0.613
Graft weight/recipient BSA −.374 <0.001 −65.92 −5.83 −1.33 0.186
Graft weight/recipient LBW −.508 <0.001 835.97 3.23 2.27 0.025
Graft weight/recipient BMI −.251 <0.001 −65.85 0.51 −.41 0.682
Donor weight/recipient weight −.506 <0.001 −519.55 −0.39 −.40 0.693
Donor BSA/recipient BSA −.527 <0.001 1802.84 0.75 1.08 0.280
Donor LBW/recipient LBW −.544 <0.001 −614.71 −0.45 −1.32 0.188
Donor BMI/recipient BMI −.295 <0.001 91.59 0.05 .15 0.884
Recipient height .642 <0.001 −53.43 −1.41 −1.06 0.291
Recipient weight .679 <0.001 −106.69 −3.20 −1.09 0.279
Recipient BSA .725 <0.001 5106.64 2.61 .96 0.341
Recipient LBW .741 <0.001 96.38 2.25 2.18 0.031
Recipient BMI .397 <0.001 14.77 0.12 .11 0.911
Recipient Scr .580 <0.001 209.46 0.22 3.46 0.001
(constant) 1973.77 .38 0.706
R = .783, F = 18.37, P <.001.
aDetermined by Pearson’s bivariate analysis.
bDetermined by linear regression multivariate analysis.
the ratio of graft weight to recipient LBW (P < 0.001,
inverse correlation), the ratio of graft weight to recipient
BMI (P = 0.049, inverse correlation), the ratio of donor
weight to recipient weight (P < 0.001, inverse correla-
tion), the ratio of donor BSA to recipient BSA (P < 0.001,
inverse correlation), the ratio of donor LBW to recipient
LBW (P < 0.001, inverse correlation), the ratio of donor
BMI to recipient BMI (P = 0.015, inverse correlation),
recipient height (P < 0.001), recipient weight (P < 0.001),
recipient BSA (P < 0.001), recipient LBW (P < 0.001),
recipient BMI (P = 0.014), and recipient post-transplant
Ucr (P < 0.001). Linear regression demonstrated inde-
pendent predictors of recipient post-transplant Scr to be
the ratio of graft weight to recipient body weight (P =
0.008, beta-coefficient = 9.176, 95% CI 0.757 to 5.042),
the ratio of graft weight to recipient BSA (P = 0.024,
beta-coefficient = −11.501, 95% CI −0.253 to −0.018),
the ratio of graft weight to recipient BMI (P = 0.005,
beta-coefficient = −4.012, 95% CI −0.917 to −0.169), re-
cipient weight (P = 0.034, beta-coefficient = −7.232, 95%
CI −0.484 to −0.019), and recipient post-transplant Ucr
(P = 0.001, beta-coefficient = 0.294, 95% CI −4.286 to
−0.175). The variables significantly correlated with the
Ucr (Table 4) were the ratio of graft weight to recipient
body weight (P < 0.001, inverse correlation), the ratio
of graft weight to recipient BSA (P < 0.001, inverse cor-
relation), the ratio of graft weight to recipient LBW (P
< 0.001, inverse correlation), the ratio of graft weight
to recipient BMI (P < 0.001, inverse correlation), the
ratio of donor weight to recipient weight (P < 0.001, in-
verse correlation), the ratio of donor BSA to recipient
BSA (P < 0.001, inverse correlation), the ratio of donor
LBW to recipient LBW (P < 0.001, inverse correlation),
the ratio of donor BMI to recipient BMI (P < 0.001, in-
verse correlation), recipient height (P < 0.001), recipient
weight (P < 0.001), recipient BSA (P < 0.001), recipi-
ent LBW (P < 0.001), recipient BMI (P < 0.001), and
recipient post-transplant Scr (P < 0.001). Linear regres-
sion demonstrated independent predictors of recipient
post-transplant Ucr to be the ratio of graft weight to re-
cipient LBW (P = 0.025, beta-coefficient = 3.227, 95%
CI 107.96 to 1563.98), recipient LBW (P = 0.031, beta-
coefficient = 2.248, 95% CI 9.10 to 183.65), and recipient
post-transplant Scr (P = 0.001, beta-coefficient = 0.218,
95% CI 89.82 to 329.09).
The variables significantly correlated with the recipient
Ccr (Table 5) were donor age (P < 0.001, inverse corre-
lation), recipient height (P = 0.014, inverse correlation),
the ratio of donor BSA to recipient BSA (P = 0.020),
the ratio of donor LBW to recipient LBW (P = 0.047),
and recipient post-transplant Scr (P < 0.001, inverse cor-
relation). Linear regression demonstrated independent
predictors of recipient post-transplant Ccr, including re-
cipient height (P < 0.001, beta-coefficient = −0.277, 95%
CI −0.61 to −0.33), the ratio of donor BSA to recipient
BSA (P = 0.043, beta-coefficient = 0.255, 95% CI 0.90
to 53.46), and recipient post-transplant Scr (P < 0.001,
beta-coefficient = −0.900, 95% CI −41.46 to −34.76).
Evaluation of other variables, including immunosup-
pression (type and dose of tacrolimus or cyclosporine,
double or triple), degree of HLA match, and the type
and duration of pretransplant dialysis (peritoneal dialy-
sis or hemodialysis), demonstrated no association with
recipient’s post-transplant Upr, Scr, Ucr, and Ccr (P >
0.050).
DISCUSSION
The influence of transplanted renal mass and the
metabolic demands of kidney transplant recipients on
outcome has been described using various surrogate
markers. These surrogates of the balance between the
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Table 5. Donor, recipient and graft characteristics correlating with or independently predicting recipient post-transplant creatinine clearance
Correlationsa Coefficientsb
Independent variables Pearson’s P value B b t P value
Donor age −.239 <0.001 −0.01 −0.01 −0.32 0.750 .613
Recipient height −.160 0.014 −0.47 −0.28 −6.54 <0.001
Donor BSA/recipient BSA .148 0.020 27.18 .26 2.04 0.043
Donor LBW/recipient LBW .122 0.047 −10.89 −.18 −1.44 0.153
Recipient Scr −.478 <0.001 −38.11 −.90 −22.46 <0.001
(constant) 121.94 8.36 <.001
R = .924, F = 178.78, P <.001.
aDetermined by Pearson’s bivariate analysis.
bDetermined by linear regression multivariate analysis.
‘demand’ and ‘supply’ have included recipient weight and
kidney size [13], recipient BMI and kidney size [14], recip-
ient weight and kidney weight [4, 15, 16], recipient BSA
and kidney weight [17], and recipient BMI and kidney
weight [1, 10, 11], as well as recipient traits and donor
traits [8, 18–21]. As the surrogate of graft outcome, long-
term and short-term graft survival and graft function have
also been observed [22, 23]. However, among the parame-
ters that attempt to measure the metabolic demands and
nephron supply, none have been determined yet as the
best proxy to predict the early graft function after kid-
ney transplantation. In the present study, we analyzed the
variables of age, weight, height, BSA, LBW, and BMI to
attempt to control for metabolic demand, and to deter-
mine the best surrogate among them.
In an attempt to estimate nephron mass, graft size or
graft weight might be used. A previous study has demon-
strated a poor correlation between the kidney size and
measured kidney weight [24]. The present study, there-
fore, used kidney weight to control for nephron mass.
In order to determine the actual number of nephrons in
the donated kidney, a routine graft biopsy would need
to be performed during the operative procedures. In the
present study, graft weight was used rather than nephron
number on biopsy because of the associated risks of
biopsy, including bleeding, hematuria, and arteriovenous
fistula in the grafted kidney.
Estimating the impact of any one factor after kid-
ney transplantation is difficult due to the complex in-
teraction of numerous other factors on outcome. In the
present study, we attempted to specifically analyze the
impact of the metabolic demands and renal supply on
graft outcome. To eliminate the possible impact of im-
munologic or nonimmunologic factors on graft function,
we excluded recipients with pre- or post-transplant di-
abetes, kidney transplants from cadaveric donors, post-
transplant ischemic injuries of the graft, episodes of re-
jection, drug toxicities, systemic or local infections, or any
complications, such as vascular or urologic adverse events
postoperatively, which resulted in functional decrease of
the kidney graft.
The present data demonstrated that as donor size in-
creased, the donated kidney weight also increased. How-
ever, the graft function, as measured by Scr, Ucr, and
Upr, was not directly correlated with the graft weight
but rather correlated with the ratios of graft weight to
the parameters of recipient’s metabolic demands. On the
other hand, as recipient size increased, the metabolic de-
mand has also increased. The parameters of recipient’s
metabolic demands, such as weight, height, BSA, LBW,
and BMI, were directly correlated with Scr and Ucr rather
than with Upr. Of note, other measures of renal function,
such as erythropoetin synthesis, electrolyte or acid base
balance, and calcium metabolism, were not evaluated in
this study.
In the clinical practice, the most useful and frequently
used laboratory test to estimate the graft function after
kidney transplantation is Scr. In this study, the ratio of
graft weight to recipient body weight was inversely cor-
related with Scr of recipient after transplantation by Pear-
son’s bivariate analysis (P < 0.001). Multivariate linear
regression demonstrated independent predictors of re-
cipient post-transplant Scr to be the ratio of graft weight
to recipient body weight (P = 0.008, beta-coefficient =
9.176, 95% CI 0.757 to 5.042). As per these findings, we
plotted the scattered graph with X-axis of the ratio of
graft weight to recipient body weight and Y-axis of re-
cipient serum creatinine. Furthermore, we calculated a
statistical fit line of the plotted cases using a fit method
of linear regression, and two regression prediction lines
for the upper and lower 95% confidence interval, as dis-
played in Figure 1. Each line was converted into the pre-
dictive formula, Scr = −0.11 × (graft weight (g)/recipient
body weight (kg)) + 1.72. Under 95% confidence, the
Scr ranges from −0.11 × (graft weight (g)/recipient body
weight (kg)) + 1.06 to −0.11 × (graft weight (g)/recipient
body weight (kg)) + 2.36.
Creatinine is constantly produced from muscle, and is
continuously excreted by the kidneys into urine. Fat com-
ponent of the recipient’s body has less of an effect on the
parameters of graft function, such as Scr, Ucr, and Upr.
However, the parameters of metabolic demands such as
body weight, body surface area, lean body weight, and
body mass index, may overestimate metabolic demand
in obese patients. Because Korean recipients and donors
in this study were relatively lean (BMI of recipient 20.4
kg/m2 ± 2.7, BMI of donors 23.0 kg/m2 ± 2.8), it is unclear
that the data could be reliable for more obese recipients
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Fig. 1. The scattered plots and the statistical fit lines by the ratio of
graft weight to recipient body weight versus recipient serum creati-
nine after transplantation. Lines indicate the fit line of the plotted
cases by fit method of linear regression (middle line), and upper (upper
line) and lower (lower line) regression prediction for 95% confidence
interval.
and donors. Further studies will be needed in an obese
population to see if ideal body weight or other parameters
are effective for prediction in obese recipients. Moreover,
given the fact that the population of this study included
adult donors and adult recipients, it is still unclear that the
data could be reliable for pediatric recipients. In general,
when the Scr of adult recipient after kidney transplanta-
tion is much higher than the ideal value by the formula,
the clinician should suspect an underlying source of graft
injury.
CONCLUSION
Our findings provide direct evidence of a substantial
effect of the balance between donor graft mass and re-
cipient metabolic demand on early graft function. During
living donor and recipient matching, both the potential
sizes of the donated kidney and the recipient should be
considered in terms of the early graft function after trans-
plantation.
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